scholarly journals EAST AZERBAIJAN POPULATION BASED CANCER REGISTRY DURING 2015 TO 2016: PRELIMINARY REPORT

2017 ◽  
Vol 2 (2) ◽  
pp. 179-179
Author(s):  
Mohammad Hossein Somi ◽  
Roya Dolatkhah ◽  
Sepideh Sepahi ◽  
Mina Belalzadeh ◽  
Leila Abdollahi ◽  
...  
Keyword(s):  
Cancer Registry ◽  
Preliminary Report ◽  
Population Based ◽  
East Azerbaijan

scholarly journals Gastric cancer in East Azerbaijan, Iran: Five-year survival analysis of population-based cancer registry results

2020 ◽  
Vol 7 (11) ◽  
pp. 4114-4121
Author(s):  
Pooneh Jabbaripour ◽  
Mohammad Hossein Somi ◽  
Hossein Mashhadi Abdolahi ◽  
Roya Dolatkhah
Keyword(s):  
Gastric Cancer ◽  
Survival Analysis ◽  
Cancer Registry ◽  
Survival Data ◽  
Cox Regression ◽  
Survival Function ◽  
Population Based ◽  
Rank Test ◽  
Cancer Data ◽  
East Azerbaijan

Introduction: Gastric cancer is the most common cancer with significant increasing trends during the last decade in Iran. The aim of this study was to evaluate the epidemiologic profile of gastric cancer along with gastric cancer-specific survival analysis. Methods: This was an analytical cross-sectional study in which all gastric cancer data were analyzed using the database of the East Azerbaijan Population-Based Cancer Registry (EA-PBCR). The incidents of definitive gastric cancer diagnosis were between the period of March 20th, 2015 to March 19th, 2017 ( = 3 Iranian solar years). The survival analysis was performed using the Kaplan-Meier method and life tables for 1- to 5-year survival data. The Log-rank test and Cox regression were computed to test the equality of survival function and mortality hazard. Results: Overall, 2,631 newly diagnosed gastric cancer cases were registered for 3 years. Gastric cancer was 2.35 times more common in men than women. The most common age group was the 7th decade- with 531 (31.2%) gastric cancer cases. Most of the gastric cancer cases were non-cardia (n = 2,244, 85.29%) cancer, and the proportion of non-cardia to cardia gastric cancer was 5.8:1. Overall survival was 60.1%, and 1- to 5-year survival proportions were 91.61%, 64.21%, 58.53%, 30.14% and 24.77%, respectively. Cardia cancers had a worse survival rate than non-cardia cancers, and the hazard of mortality was 1.33 times higher in cardia than non-cardia cancers (hazard ratio or HR = 1.33; 95% CI: 1.05 - 1.68; P = 0.017). Conclusion: Non-cardia gastric cancer is still the most dominant subsite in East Azerbaijan, Iran. There was a higher 1- to 5- year survival proportion in East Azerbaijan, with lower overall mortality rates, compared to other regions of Iran.

scholarly journals A 12-year trend analysis of the incidence of gastrointestinal cancers in East Azerbaijan: last updated results of an ongoing population-based cancer registry

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Mohammad Hossein Somi ◽  
Roya Dolatkhah ◽  
Sepideh Sepahi ◽  
Mina Belalzadeh ◽  
Shahnaz Naghashi ◽  
...  
Keyword(s):  
Trend Analysis ◽  
Cancer Registry ◽  
Population Based ◽  
Gastrointestinal Cancers ◽  
East Azerbaijan

scholarly journals Breast cancer distribution in East Azerbaijan, Iran: Results of population-based cancer registry

2019 ◽  
Vol 30 ◽  
pp. ix4
Author(s):  
S. Pashaei ◽  
R. Dolatkhah ◽  
M.H. Somi ◽  
R. Asghari
Keyword(s):  
Breast Cancer ◽  
Cancer Registry ◽  
Population Based ◽  
East Azerbaijan

scholarly journals Cancer incidence in the East Azerbaijan province of Iran in 2015–2016: results of a population-based cancer registry

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Mohammad Hossein Somi ◽  
Roya Dolatkhah ◽  
Sepideh Sepahi ◽  
Mina Belalzadeh ◽  
Jabraeil Sharbafi ◽  
...  
Keyword(s):  
Cancer Registry ◽  
Cancer Incidence ◽  
Population Based ◽  
East Azerbaijan

scholarly journals Does access to care play a role in liver cancer survival? The ten-year (2006–2015) experience from a population-based cancer registry in Southern Italy

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Walter Mazzucco ◽  
Francesco Vitale ◽  
Sergio Mazzola ◽  
Rosalba Amodio ◽  
Maurizio Zarcone ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Access To Care ◽  
Cancer Registry ◽  
Health Care Services ◽  
Cancer Survival ◽  
Developed Countries ◽  
Population Based ◽  
Easy Access ◽  
Net Survival ◽  
Poor Access

Abstract Background Hepatocellular carcinoma (HCC) is the most frequent primary invasive cancer of the liver. During the last decade, the epidemiology of HCC has been continuously changing in developed countries, due to more effective primary prevention and to successful treatment of virus-related liver diseases. The study aims to examine survival by level of access to care in patients with HCC, for all patients combined and by age. Methods We included 2018 adult patients (15–99 years) diagnosed with a primary liver tumour, registered in the Palermo Province Cancer Registry during 2006–2015, and followed-up to 30 October 2019. We obtained a proxy measure of access to care by linking each record to the Hospital Discharge Records and the Ambulatory Discharge Records. We estimated net survival up to 5 years after diagnosis by access to care (“easy access to care” versus “poor access to care”), using the Pohar-Perme estimator. Estimates were age-standardised using International Cancer Survival Standard (ICSS) weights. We also examined survival by access to care and age (15–64, 65–74 and ≥ 75 years). Results Among the 2018 patients, 62.4% were morphologically verified and 37.6% clinically diagnosed. Morphologically verified tumours were more frequent in patients aged 65–74 years (41.6%), while tumours diagnosed clinically were more frequent in patients aged 75 years or over (50.2%). During 2006–2015, age-standardised net survival was higher among HCC patients with “easy access to care” than in those with “poor access to care” (68% vs. 48% at 1 year, 29% vs. 11% at 5 years; p < 0.0001). Net survival up to 5 years was higher for patients with “easy access to care” in each age group (p < 0.0001). Moreover, survival increased slightly for patients with easier access to care, while it remained relatively stable for patients with poor access to care. Conclusions During 2006–2015, 5-year survival was higher for HCC patients with easier access to care, probably reflecting progressive improvement in the effectiveness of health care services offered to these patients. Our linkage algorithm could provide valuable evidence to support healthcare decision-making in the context of the evolving epidemiology of hepatocellular carcinoma.

Sign in / Sign up

Export Citation Format

Share Document